From genetic variation to precision medicine
Cambridge Prisms: Precision Medicine · 2023
DOI: 10.1017/pcm.2022.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cambridge Prisms: Precision Medicine, 2023. Verfasst von Panagiotis I Sergouniotis und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manc…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, National Institute for Health and Care Research.
Abstract (Originalsprache)
Genetics has been an important tool for discovering new aspects of biology across life. In humans, there is growing momentum behind the application of this knowledge to drive innovation in clinical care, most notably through developments in precision medicine. Nowhere has the impact of genetics on clinical practice been more striking than in the field of rare disorders. For most of these conditions, individual disease susceptibility is influenced by DNA sequence variation in a single or a small number of genes. In contrast, most common disorders are multifactorial and are caused by a complex interplay of multiple genetic, environmental and stochastic factors. The longstanding division of human disease genetics into rare and common components has obscured the continuum of human traits and echoes aspects of the century-old debate between the Mendelian and biometric views of human genetics. In this article, we discuss the differences in data and concepts between rare and common disease genetics. Opportunities to unify these two areas are noted and the importance of adopting a holistic perspective that integrates diverse genetic and environmental factors is discussed.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.
- Manchester Centre for Genomic Medicine, Saint Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
- Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
ORCID-Profile: Panagiotis I Sergouniotis
Förderung
- Wellcome Trust
- National Institute for Health and Care Research
Zitieren
APA
Sergouniotis, P. I., Fitzgerald, T., & Birney, E. (2023). From genetic variation to precision medicine. Cambridge Prisms: Precision Medicine. https://doi.org/10.1017/pcm.2022.11
Vancouver
Sergouniotis PI, Fitzgerald T, Birney E. From genetic variation to precision medicine. Cambridge Prisms: Precision Medicine. 2023. doi:10.1017/pcm.2022.11
BibTeX
@article{Sergouniotis2023,
author = {Sergouniotis, Panagiotis I and Fitzgerald, Tomas and Birney, Ewan},
title = {From genetic variation to precision medicine},
journal = {Cambridge Prisms: Precision Medicine},
year = {2023},
doi = {10.1017/pcm.2022.11}
}
EUVIMED